Expanding chemical probe space: quality criteria for covalent and degrader probes

IV Hartung, J Rudolph, MM Mader… - Journal of Medicinal …, 2023 - ACS Publications
Within druggable target space, new small-molecule modalities, particularly covalent
inhibitors and targeted degraders, have expanded the repertoire of medicinal chemists …

How many kinases are druggable? A review of our current understanding

B Anderson, P Rosston, HW Ong… - Biochemical …, 2023 - portlandpress.com
There are over 500 human kinases ranging from very well-studied to almost completely
ignored. Kinases are tractable and implicated in many diseases, making them ideal targets …

Delineating cysteine-reactive compound modulation of cellular proteostasis processes

AR Julio, F Shikwana, C Truong, NR Burton… - Nature Chemical …, 2024 - nature.com
Covalent modulators and covalent degrader molecules have emerged as drug modalities
with tremendous therapeutic potential. Toward realizing this potential, mass spectrometry …

Biophysical and computational approaches to study ternary complexes: a 'cooperative relationship'to rationalize targeted protein degradation

JA Ward, C Perez‐Lopez, C Mayor‐Ruiz - ChemBioChem, 2023 - Wiley Online Library
Degraders have illustrated that compound‐induced proximity to E3 ubiquitin ligases can
prompt the ubiquitination and degradation of disease‐relevant proteins. Hence, this …

Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research

J Sterling, JR Baker, A McCluskey, L Munoz - Nature Communications, 2023 - nature.com
Chemical probes have reached a prominent role in biomedical research, but their impact is
governed by experimental design. To gain insight into the use of chemical probes, we …

Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets

MP Schwalm, J Dopfer, A Kumar, FA Greco… - Nature …, 2024 - nature.com
Recent successes in develo** small molecule degraders that act through the ubiquitin
system have spurred efforts to extend this technology to other mechanisms, including the …

Small molecules targeting DNA polymerase theta (POLθ) as promising synthetic lethal agents for precision cancer therapy

MC Pismataro, A Astolfi, ML Barreca… - Journal of medicinal …, 2023 - ACS Publications
Synthetic lethality (SL) is an innovative strategy in targeted anticancer therapy that exploits
tumor genetic vulnerabilities. This topic has come to the forefront in recent years, as …

[HTML][HTML] A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis

H Hu, A Tjaden, S Knapp, AA Antolin, S Müller - Cell chemical biology, 2023 - cell.com
Summary Drug-induced phospholipidosis (DIPL), characterized by excessive accumulation
of phospholipids in lysosomes, can lead to clinical adverse effects. It may also alter …

Which small molecule? selecting chemical probes for use in cancer research and target validation

MM Mader, J Rudolph, IV Hartung, D Uehling… - Cancer Discovery, 2023 - AACR
Small-molecule chemical “probes” complement the use of molecular biology techniques to
explore, validate, and generate hypotheses on the function of proteins in diseases such as …

canSAR 2024—an update to the public drug discovery knowledgebase

PW Gingrich, R Chitsazi, A Biswas, C Jiang… - Nucleic acids …, 2025 - academic.oup.com
Abstract canSAR (https://cansar. ai) continues to serve as the largest publicly available
platform for cancer-focused drug discovery and translational research. It integrates …